Evitrade - Press Release - Pot Stock Watch

Evitrade Health Systems (CSE:EVA) Has Bottomed On Big News. Stock Volume Up!

Looking for an under-the-radar pot stock in the red-hot cannabis market that is positioning itself to breakout and explode like Aurora, Canopy Growth Corp. and Namaste Technologies have done?

Take a good look at Evitrade Health Systems (CSE:EVA), as recent price action coupled with excellent news has this stock bottoming and moving higher fast!

Technically – The Bottom Is In on Evitrade Health Systems (CSE:EVA)

EVA is a fast mover in the CBD market, which is projected to hit $22 billion in value in just three years.

Evitrade (CSE:EVA) is pleased to report that the development of its Nevada based hemp extraction facility is way ahead of schedule.

Over the past few months, Mr. Brown, President of Western Agri Solutions Supply Corp (”WASSC”), a wholly owned subsidiary of EviTrade, has made great strides in the process of bringing the facility on-line.

Evitrade’s (CSE:EVA) new facility will be able to process enough hemp to produce approximately 200Kgs of CBD isolate per month.

With this volume of throughput, Evitrade (CSE:EVA) will be able to satisfy sales channels with a line of premium CBD based products subject to applicable federal and local laws.

From a purely technical perspective Evitrade Health Systems(CSE:EVA) boasts a massive upside day Friday, with a 300% increase in volume.

Price action is expected to “breakout” here extremely fast, as these undervalued CBD companies come into focus.

Large Weekly Candle Developing on Evitrade

About EVITRADE Health (CSE: EVA, OTCQB: EVAHF)

EVITRADE Health Systems Corp. (formerly, Auxellence Health Corporation), is a technology company specializing in the Health and Life Sciences sector looking to deliver effective personalized health solutions with a higher degree of predictability and consistency.

The Company is focused on the following areas to help improve health: personalized medical care (including CBD usage monitoring and effects on the cardiovascular system), molecular biology, nutraceutical solutions and genetic tailoring.

Through its subsidiaries’ focus on technologies involved in extracting and purifying CBD extracts for its personalized healthcare system, the Company may be the first to offer a complete quality assured vertically integrated ”CBD Health System” for monitoring and recording the effects of CBD on your cardiovascular system.